[A liver biopsy specimen model to study the quality improvement and process optimization through failure mode and effects analysis].

Tang, H; Lu, Z H; Zhang, R R; Xu, R R; Fang, K.

Afiliação

Tang H; Department of Pathology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi 214002, China.
Lu ZH; Department of Hepatology, The Affiliated Wuxi No.5 People's Hospital of Nanjing Medical University, Wuxi 214016, China.
Zhang RR; Department of Pathology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi 214002, China.
Xu RR; Department of Pathology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi 214002, China.
Fang K; Department of Pathology, Yixing People's Hospital, Yixing 214200, China.

Zhonghua Gan Zang Bing Za Zhi ; 27(3): 210-212, 2019 Mar 20.

Article em Zh | MEDLINE | ID: mdl-30929338